$15.90 0.28 (+1.79%)
2/13/2012 10:21 AM

NuVasive, Inc. (NASDAQ:NUVA)

CAPS Rating: 2 out of 5

A medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.

Results 1 - 20 of 28 : 1 2 Next »

Recs

1
Member Avatar Momentum21 (97.21) Submitted: 10/28/2011 4:02:35 PM : Outperform Start Price: $14.93 NUVA Score: -0.40

bought a few shares for my wife's IRA today at $14.90. I have been watching and haven't liked what I have seen since it traded over $30. Given the sales growth I am willing to gamble on what appears to be crappy management of the expense side. No doubt that there must be some problems but they seem to have enough at stake to eventually get their act together.

Earnings were pretty horrendous...given the past year performance I am banking on the fact that this is capitulation day. : )

Recs

0
Member Avatar p1a5244 (74.92) Submitted: 9/18/2011 11:20:33 PM : Outperform Start Price: $21.83 NUVA Score: -41.41

9/18/11 Options Predictor Rank #32. P/C Ratio 0.074 and Call Sizzle 3.794.

Recs

0
Member Avatar montgomeryil (20.97) Submitted: 1/17/2011 11:45:15 AM : Underperform Start Price: $27.95 NUVA Score: +48.63

While this stock appears to be solid on the fundamentals, the company in 2009 issued over 60 M new shares (thanks for the dilution without any dividends), and this January, it just gave away nearly - yes, at a $0 acquisition - 150,000 shares to its officers. These officers don't appear to care about the stock price either. Checking at Yahoo Finance shows that the company's officers exercised their stock options, then sold them time after time from July 2009 though the present. Looking at their long-term stock values, they had steadily increasing value from January 2006 until July of 2008. After that, the stock become very volatile, and it just so happens to coincide with greedy management exercising and selling off their options. Until the company starts either buying back its shares or paying a dividend, this Fool is not interested.

Recs

1
Member Avatar Acorn17 (90.92) Submitted: 11/17/2010 4:49:58 AM : Outperform Start Price: $24.73 NUVA Score: -50.02

This company is growing rapidly, has a strong market and a bright future. This is a bet that the pounding it just took is overdone. One BIG reservation that I have is the way that they give away stock options like candy at a Halloween party. Despite booking large losses in previous years they doled out multi-millions in stock based comp. This past quarter (Q3 2010) they wiped out half of net income with stock option related comp. Based on the pounding it's taken from the last earnings release (off over 45% from the highs) most options are now (fortunately for stockholders) underwater. I'm thinking about buying this one for real, but the way they treat their owners is giving me pause. Great product, great company, but waiting to see how they treat the owners. . .

Recs

1
Member Avatar MrEuro (57.87) Submitted: 11/17/2010 4:20:37 AM : Outperform Start Price: $24.39 NUVA Score: -50.18

I am a fan of this industry. I have real money in ISRG but I am thinking about taking the plunge into this stock

Recs

1
Member Avatar whomonkyoulus (28.07) Submitted: 11/10/2010 3:47:50 AM : Outperform Start Price: $24.52 NUVA Score: -47.84

Oh whatever... They are still making 50 million/year and growing; that is a price/EBITDA of 20. The margin on sales is 85%. If they cannot find buyers here, then they surely will elsewhere.

Recs

1
Member Avatar 21popsontop (< 20) Submitted: 11/1/2010 4:17:19 PM : Outperform Start Price: $25.72 NUVA Score: -52.33

Longshots slipp'en and slid'en away,gett'en near over sold I do believe,only to see a better day the old fasion way . Did management say bankrupt,NO,not even close,but one would think so,as everyone flee's. One question? What day do they come back? Not sure,watch for the keys,but that they will indeed.

Recs

0
Member Avatar actionlogos (< 20) Submitted: 6/30/2010 7:10:13 PM : Outperform Start Price: $35.65 NUVA Score: -87.06

quality product, self marketing products, expanding into international markets.

Recs

0
Member Avatar FinanceGuy58 (41.65) Submitted: 12/13/2009 1:26:23 PM : Outperform Start Price: $28.43 NUVA Score: -69.20

Stock being hammered by short speculation and concerns over reimbursement. I think the concerns are overblown and this could be an easy double.

Recs

0
Member Avatar NUWildcat77 (< 20) Submitted: 10/30/2009 2:41:16 PM : Outperform Start Price: $35.36 NUVA Score: -86.21

Rapid revenue growth in minimally invasive spine surgery

Recs

0
Member Avatar pedromigz (23.93) Submitted: 9/14/2009 12:54:03 PM : Outperform Start Price: $41.99 NUVA Score: -92.34

pt47, z1

Recs

0
Member Avatar cyberccs (63.25) Submitted: 7/11/2009 2:35:04 AM : Outperform Start Price: $38.80 NUVA Score: -113.34

bull

Recs

0
Member Avatar power2macs (< 20) Submitted: 7/8/2009 3:33:38 AM : Outperform Start Price: $39.91 NUVA Score: -113.97

better tech and mkting force thans comps

Recs

0
Member Avatar monkeyking55 (< 20) Submitted: 11/17/2008 10:44:46 PM : Outperform Start Price: $39.71 NUVA Score: -123.21

As u can see in the stock trends, it is already higher then S&P 500 and it's going to keep outperforming S&P 500. Nuvasive has a product that everybody needs. Look at there sales and stock price in the past couples of yeear, they outperformed wall street prediction.

Recs

0
Member Avatar tableScraps (< 20) Submitted: 10/25/2008 6:14:33 AM : Outperform Start Price: $41.31 NUVA Score: -122.31

innovative product.

Recs

0
Member Avatar stockguy07 (< 20) Submitted: 9/2/2008 12:52:23 PM : Outperform Start Price: $48.50 NUVA Score: -76.75

TM

Recs

1
Member Avatar shekoe (< 20) Submitted: 6/20/2008 8:41:20 AM : Outperform Start Price: $45.79 NUVA Score: -70.65

Makes complete systems for minimally invasive spine fusion surgery. The older we get, the more likely we are to need such surgery. I think the stock is the next Intuitive Surgical (ISRG).

Recs

0
Member Avatar jatava (90.19) Submitted: 5/21/2008 10:47:44 PM : Outperform Start Price: $39.68 NUVA Score: -61.10

6.000

Recs

1
Member Avatar YODSTER (71.27) Submitted: 1/4/2008 3:52:08 PM : Outperform Start Price: $39.10 NUVA Score: -59.77

This stock is awesome. I wouldn't have even known about it, but I sat next to an employee on an aircraft and he amazed me with the technology this co. is coming up with for what used to be tremendously invasive surg. Back surg. done via laparoscopy essentially....I look for this to hit the 100 mark in 5 yrs.

Recs

0
Member Avatar BetterMoney77 (< 20) Submitted: 12/6/2007 4:36:22 AM : Outperform Start Price: $41.99 NUVA Score: -57.96

Nice solid chart pattern (technically) with fabulous growth (fundamentally).

Results 1 - 20 of 28 : 1 2 Next »

Featured Broker Partners


Advertisement